Analysis of Associations Between Advanced Glycation end-Products and Vascular Complications of type 2 Diabetes
- 30 September 2024
- conference paper
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 248-252
Abstract
The aim of the study: to determine the predictive value of advanced glycation end-products and their receptor in prognostic model for vascular complications of type 2 diabetes. Materials and Methods: 126 patients with type 2 diabetes (T2D), 55 males and 71 females were included. Testing for diabetes complications, comorbidities and laboratory parameters was realized. A duplex ultrasound of the carotid and lower extremities arteries was conducted for all patients to reveal or exclude the atherosclerosis. Serum concentrations of AGEs (advanced glycation end products) and RAGE (receptor for advanced glycation end products) were determined by enzyme-linked immunosorbent assay. Results: based on ultrasound data the examined patients were divided in three groups. First group without atherosclerosis (ATO, $\mathrm{n}=39)$ . Second group with atherosclerosis of carotid arteries $(\text{AT}1,\ \mathrm{n}=47)$ . Third group included the patients with atherosclerosis of carotid arteries and lower extremities $(\text{AT}2,\ \mathrm{n}=40)$ . The groups were similar by age and sex. The atherosclerosis was associated with T2D duration, lower BMI, diabetic nephropathy and chronic kidney disease. The differences in other clinical and metabolic parameters were not revealed. Serum concentrations of AGEs and RAGEs did not differ in the study groups. The correlation analysis revealed relationships between the AGEs and microalbuminuria $(\mathrm{r}=0.69,\ \mathrm{p} < 0.05)$ and urine albumin-creatinine ratio $(\mathrm{r}=0.67,\mathrm{p} < 0.05)$ . Conclusion: in T2D patients, serum levels of AGEs is associated with diabetic nephropathy. AGEs and RAGEs did not predict an atherosclerosis development and progression.
Keywords
This publication has 23 references indexed in Scilit:
- Association Between the Tissue and Circulating Advanced Glycation End-Products and the Micro- and Macrovascular Complications in Type 1 Diabetes: The DIABAGE StudyDiabetes Therapy, 2022
- Advanced glycation end products (AGEs) and their soluble receptors (sRAGE) as early predictors of reno-vascular complications in patients with uncontrolled type 2 diabetes mellitusDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2019
- Epidemiology of Diabetes Mellitus and Cardiovascular DiseaseCurrent Cardiology Reports, 2019
- RAGE-TLR Crosstalk Sustains Chronic Inflammation in NeurodegenerationMolecular Neurobiology, 2017
- Telmisartan inhibits AGE-induced podocyte damage and detachmentMicrovascular Research, 2013
- The emerging challenge in diabetes: The “metabolic memory”Vascular Pharmacology, 2012
- Glycated collagen alters endothelial cell actin alignment and nitric oxide release in response to fluid shear stressJournal of Biomechanics, 2011
- Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force Endorsed by the Society for Vascular MedicineJournal of the American Society of Echocardiography, 2008
- Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settingsAdvanced Drug Delivery Reviews, 2002
- What is oxidative stress?Metabolism, 2000